Survival rates for 4 common, high-risk surgical procedures vary significantly hospital-to-hospital, according to the findings of a new report from The Leapfrog Group and Castlight Health.
Survival rates for high-risk surgical procedures vary significantly hospital-to-hospital, according to the findings of a new report from The Leapfrog Group and Castlight Health.
The report focused on 4 specific procedures that are both common and high-risk: abdominal aortic aneurysm (AAA) repair, aortic valve replacement (AVR), pancreatectomy, and esophagectomy. The report includes predicted survival rates, by hospital, for each type of surgery.
“The frequency of these high-risk surgical procedures is expected to increase as the US population ages, making the report findings that much more important,” Jennifer Schneider, MD, MS, chief medical officer for Castlight Health, said in a statement. “Beyond the devastating personal and emotional toll of a poor outcome on patients and providers, there is the notable financial burden on the US health care system when less-than-optimal care is delivered. By every measure, these findings warrant attention and immediate action.”
Leapfrog found that the variation in the survival rate for a pancreatectomies varies 19 percentage points across hospitals, with predicted survival rates ranging from 81% to 100%. The survival rate for AAA repair varies 13 percentage points from 86% to 99%; for AVR the survival rate varies 5 percentage points from 92% to 97%; and for esophagectomy the survival rate varies 10 percentage points from 88% to 98%.
The predicted survival rate is calculated using the number of patients who had the surgery at a given hospital and the number of those who died after having the procedure at that hospital. The report provided additional steps for hospitals and stakeholders to take to ensure patients receive the best care:
“We strongly encourage consumers to examine their local hospitals’ performance on these high-risk procedures, as the data on survival rates enables patients to gauge their likelihood of surviving each procedure at a given hospital,” Leah Binder, president and chief executive officer of Leapfrog, said.